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bstract
The peritoneum is the largest serous membrane of the body and can be exposed to several injuries that may cause abnormal findings on imaging
xams. Linear peritoneal calcification is remarkably rare, usually secondary to long duration peritoneal dialysis.
We report an uncommon case of extensive peritoneal calcification in a 39-year-old female without long exposure to peritoneal dialysis solutions,
n which peritoneal calcification could be linked to Alport syndrome and previous adverse reaction to intraperitoneal iodinated contrast.
Radiologist should be aware of this and related imaging findings, know when to search for them as well as understand their clinical value.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA license (http://creativecommons.
rg/licenses/by-nc-sa/3.0/).
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.  Introduction
Cases of linear peritoneal calcification have been reported
n literature, though they occur rarely. In Encapsulating Perit-
neal Sclerosis (EPS) a peritoneal membrane damage develops
n inflammatory cascade that results in sclerosis and eventually
alcification [1].
EPS has been can be either primary or secondary, being long
The diagnosis of EPS combines clinical symptoms with
pathological and imaging findings [5]. The symptoms mani-
fest disturbances in intestinal function such as abdominal pain,
nausea, vomiting and ultimately anorexia and weight loss [6].
Among the imaging techniques available, CT is the modality
of choice in the diagnosis of EPS, demonstrating peritoneal
thickening, calcification, bowel wall thickening, bowel tether-
ing, dilation and fluid loculation [5]. Final diagnosis requiresxposure to peritoneal dialysis solutions [2,3] the most common
ause of the secondary form. The incidence of EPS has only
een studied in patients on peritoneal dialysis and is estimated
o be 0.54–4.4% [4], although this number can rise considerably
ith the time on PD.
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rg/licenses/by-nc-sa/3.0/).irect observation of peritoneum and histology [7].
In a symptomatic patient, the mortality associated with EPS
s high, reaching 60% 4 months after the diagnosis [6]
.  Case  presentationIn August 2014 a 39-year-old female presented to the emer-
ency department of our hospital. She had Alport disease,
nd-stage renal disease and secondary hyperparathyroidism.
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Fig. 1. An abdominal CT was obtained with iodinated contrast injected through
the peritoneal catheter (CT peritoneography). The exam revealed a good diffu-
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Fig. 2. A lumbar radiography showed diffuse peritoneal calcification, most
evident in the lower abdomen.
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patient was hospitalized. Blood cultures were negative, whileion of contrast, with no images of leak or abdominal collections.
he referred a past history of one cesarean followed by a
aparoscopic tubal ligation. In October 2013 she initiated
eritoneal dialysis. The catheter introduced was soon found dys-
unctional, with no drain of dialysate. Laparoscopic removal
f adhesions and catheter repositioning were performed, but
omplicated with hemoperitoneum. Peritoneal lavage by the per-
toneal catheter was performed, but abdominal wall swelling
as noticed and a leak within the laparoscopic port was
uspected.
A CT peritoneography (Fig. 1) was obtained to search for
n abdominal leak. Iodinated contrast was injected through the
eritoneal catheter and the patient was encouraged to walk,
llowing a good diffusion of contrast through the peritoneal
avity. Shortly after contrast injection the patient developed
ntense abdominal pain and hypotension that were attributed
o contrast adverse reaction. The CT was obtanied 30 min after
ontrast injection, revealing a good diffusion of contrast, with
o images of leak or abdominal collections. The contrast was
hen drained through the catheter. Ten days later the patient was
een for abdominal pain and elevated inflammatory markers (C-
eactive protein = 40) and the Tenckhoff catheter was removed
or a suspected infection. Cultures of peritoneal fluid were neg-
tive. Antibiotics for twelve days were given and the patient
mproved clinically and analytically. The patient chose then to
tart hemodialysis.
On the day she visited our emergency department, she
eported complaints of lumbar pain and dysuria for the pre-
ious few days. She had no nausea nor vomiting. She had
o fever. On physical examination the abdomen was soft
nd nontender. The bowel sounds were normal. Labora-
ory data were normal, except for: hemoglobin = 8.9 (normal
2–16 g/dL), leukocytosis = 14,700 (4000–10,000), leukocy-
uria > 200/field (<5/field); C-reactive protein = 23.5 (<1.0),
rea = 22.4 (2.4–6.4 mmol/L), creatinine = 316 (46–92 mol/L),
TH = 324 (16–87 pg/mL), calcium = 2.40 (2.10–2.55 mmol/L)
nd phosphorus 1.47 (0.41–1.45 mmol/L).
E
c
dA plain lumbar radiography (Fig. 2) showed diffuse perit-
neal calcification, most evident in the lower abdomen. There
ere no abnormalities of the lumbar spine. Renal ultrasound
as normal, with no signs of renal obstruction.
The abdominal CT (Fig. 3) revealed extensive visceral
arrows in a) and parietal peritoneal calcification (arrowheads
n a) with areas of focal thickening in the pelvic peritoneum
arrowheads in c).
Antibiotics to the urinary infection were given and thescherichia  coli  was isolated in the urine culture. She improved
linically, inflammatory markers decreased and she was then
ischarged from the hospital with no symptoms.
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Fig. 3. The abdominal CT without contrast revealed extensive visceral (arrows in a) and parietal peritoneal calcification (arrowheads in a) with areas of focal
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.  Discussion
Cases of linear peritoneal calcification have been reported in
atients on long-standing peritoneal dialysis and have previously
een classified as “Calcifying Peritonitis” [8,9]. This term is not
urrently used but is now included in the spectrum of EPS [8].
EPS has been described as primary or, more frequently, sec-
ndary. Long exposure to peritoneal dialysis solutions is the
ost cited caused, although it can also develop after renal-
ransplant [10], with hyperparathyroidism [8,11], with the use of
ertain beta-blockers [3] or after recurrent episodes of peritonitis
8,12], among others. Sampimon [13] demonstrated an increased
usceptibility for patients with Alport disease to develop EPS.
The “two-hit” model has been used to explain the patho-
hysiology of EPS, hypothesizing that a predisposing factor
injury) and an initiating factor (such as an inflammatory stimuli)
re required for EPS to develop [14]. From this model we can
ssume that, in a susceptible patient, it can develop after any
eritoneal inflammatory stimuli. Eisenberg and colleagues [15]
eported the development of peritoneal inflammation secondary
o iodinated contrast agents in Guinea-pigs.
To the best of our knowledge no cases of EPS secondary
o intraperitoneal contrast have been reported. This can be
xplained by the low frequency of its use. Nevertheless we
elieve that it could have been the cause of our imaging findings.
Clinically, patients with EPS can be asymptomatic or may
resent with symptoms caused by modifications of gastroin-
estinal transit. Nakamoto [16] divided EPS into four clinical
nd pathological progressive stages, ranging from lack of symp-
oms in stage 1 to complete bowel obstruction and anorexia
haracterizing the stage 4.
Imaging findings will translate the pathological progression
f the disease, with peritoneal calcification predominating in the
arly stages and the most advanced cases presenting with find-
ngs of bowel obstruction such as air-fluid levels, dilated loops
r even bowel clustering. On the different imaging techniques,
a
pbdominal radiography shows a low accuracy in this diagnosis,
eing either normal or revealing peritoneal calcification, air-fluid
evels or loop dilations [5]. Contrast studies can reveal proximal
mall bowel dilatation, delayed transit time and, in advanced
ases, “cauliflower sign” attributable to lower quadrant agglom-
ration of bowel loops [17]. Abdominal ultrasound can show
eritoneal thickening, loculated peritoneal fluid, peritoneal cal-
ification, adherences, dilated or diminished peristaltic intestinal
oops [5]. Contrast CT is regarded as the imaging modality of
hoice [5]. Diagnostic criteria have been developed by Tarzi
18] and Vlijm [19]. Tarzi created a 22-point score, considering
eritoneal thickening, peritoneal calcification, bowel wall thick-
ning, bowel tethering (0–4 points each), loculation and bowel
ilation (0–3 points). The mean score of EPS patients was 9
2–16), comparing to an average score of 1 (0–3) in controls
atients on peritoneal dialysis. Magnetic Resonance has been
roposed, although less studied in these patients [20]. Positron
mission tomography can show an increased peritoneal uptake
ut is not able to distinguish from acute peritonitis [5].
In our case, the diagnosis was made by CT, although it could
lready be suspected by the radiography. No intravenous con-
rast was given due to the previous reaction to contrast. Our
atient CT score is 5, inferior to the average obtained by Tarzi,
ut matching an early stage of disease that we expected due to
he lack of symptoms (stage 1). The focal peritoneal thickening
bserved in the most dependent portions of the abdomen might
e explained by the longer time exposure of these areas to the
eritoneal contrast.
Definitive diagnosis is made from direct observation of peri-
oneum and histology. Laparotomy is indicated in later stages of
he disease and shows peritoneal thickening, adhesions, tether-
ng, fibrosis or bowel retraction [7]. Histological changes in the
eritoneum include interstitial fibrosis, capillary proliferation
nd calcification [7].
No specific treatment has been developed for EPS, being
roposed the use of total parenteral nutrition [3,21], corticoids
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3,21], tamoxifen [22,23] and surgery with enterolysis of intesti-
al adhesions for advanced cases [3,21]. When presenting with
ymptoms EPS has a high mortality, usually as a result of bowel
bstruction, malnutrition and sepsis [6].
We demonstrated an unusual case of peritoneal calcification,
n which there was no history of long exposure to peritoneal
ialysis solutions. We believe that intraperitoneal iodinated con-
rast exposure combined with Alport syndrome have caused the
bnormalities seen. Long standing hyperparathyroidism might
lso have played a role explaining the increased susceptibility
f our patient for the development of EPS.
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